Filing Details
- Accession Number:
- 0000899243-20-027726
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-10-07 17:12:20
- Reporting Period:
- 2020-10-05
- Accepted Time:
- 2020-10-07 17:12:20
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1629137 | Global Blood Therapeutics Inc. | GBT | Pharmaceutical Preparations (2834) | 274825712 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1784038 | Eric Fink | C/O Global Blood Therapeutics, Inc. 181 Oyster Point Boulevard South San Francisco CA 94080 | Chief Human Resources Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2020-10-05 | 4,532 | $60.00 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 12, 2020.
Billionaire Hedge Funds
